Margaret Dalesandro

Margaret Dalesandro

Director/Board Member presso SKYE BIOSCIENCE, INC.

Patrimonio netto: 690 $ in data 31/03/2024

77 anni
Health Technology
Consumer Services
Electronic Technology

Profilo

Margaret R.
Dalesandro
is the founder and currently holds multiple positions.
She founded Brecon Pharma Consulting LLC in 2012 and serves as the President.
Additionally, Dr. Dalesandro currently holds the following positions: Independent Director at Skye Bioscience, Inc. since 2020, Director at Emerald Health Bioceuticals, Inc. since 2020, Independent Director at Seelos Therapeutics, Inc. since 2021, and Independent Director at Ambrx Biopharma Cayman, Inc. since 2023.
Dr. Dalesandro has held former positions as well.
She was the Director of Immunobiology & Diagnostic Research at Centocor, Inc. from 1989 to 1998.
From 2009 to 2012, she served as the Business Director of Integrative Pharmacology at Corning, Inc. Dr. Dalesandro was also an Independent Director at OncoSec Medical, Inc. from 2019 to 2020.
She held the position of Executive Director of Project & Portfolio Management at GSK Plc from 2000 to 2002.
Additionally, Dr. Dalesandro was the VP of Project, Portfolio & Alliance Management at ImClone LLC from 2002 to 2009.
She also served as an Independent Director at Ambrx Biopharma, Inc. from 2023 to 2024.
In terms of education, Dr. Dalesandro holds a graduate degree and a doctorate from Bryn Mawr College.
She also has an undergraduate degree from Rosemont College.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
04/01/2024 1 167 ( 0.01% ) 690 $ 31/03/2024
29/02/2024 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Margaret Dalesandro

SocietàPosizioneInizio
SKYE BIOSCIENCE, INC. Director/Board Member 07/08/2020
SEELOS THERAPEUTICS, INC. Director/Board Member 01/09/2021
Brecon Pharma Consulting LLC Founder 01/09/2012
Director/Board Member 01/02/2020
Director/Board Member 01/09/2023
Tutte le posizioni attive di Margaret Dalesandro

Precedenti posizioni note di Margaret Dalesandro

SocietàPosizioneFine
ONCOSEC MEDICAL INCORPORATED Chief Executive Officer 13/12/2021
CORNING INCORPORATED Corporate Officer/Principal 01/01/2012
Corporate Officer/Principal 01/01/2009
GSK PLC Corporate Officer/Principal 01/01/2002
Vedi nel dettaglio l'esperienza di Margaret Dalesandro

Formazione di Margaret Dalesandro

Bryn Mawr College Doctorate Degree
Rosemont College Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Margaret Dalesandro

Relazioni

100 +

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
CORNING INCORPORATED

Electronic Technology

ONCOSEC MEDICAL INCORPORATED

Health Services

GSK PLC

Health Technology

SKYE BIOSCIENCE, INC.

Health Technology

SEELOS THERAPEUTICS, INC.

Health Technology

Aziende private5

Health Technology

Health Technology

Health Technology

Brecon Pharma Consulting LLC

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Margaret Dalesandro